Inventor
ZHENG GUANGRONG
US21 patents
⚠️ This page may combine multiple inventors who share the name “ZHENG GUANGRONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV KENTUCKY RES FOUND
8 patentsUS10668030B2Jun 2, 2020
Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
UNIV KENTUCKY RES FOUND10 citations80
US11999676B2Jun 4, 2024
Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
UNIV KENTUCKY RES FOUND1 citations56
US6703406B2Mar 9, 2004
2,6-disubstituted piperidines as modulators of nicotinic acetylcholine receptor mediated neurotransmitter release, uptake and storage
UNIV KENTUCKY RES FOUND5 citations55
US8703803B2Apr 22, 2014
Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
UNIV KENTUCKY RES FOUND0 citations50
US9550753B2Jan 24, 2017
Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
UNIV KENTUCKY RES FOUND0 citations49
US9649301B2May 16, 2017
Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
UNIV KENTUCKY RES FOUND0 citations48
US8940774B2Jan 27, 2015
Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
UNIV KENTUCKY RES FOUND0 citations48
US7368443B2May 6, 2008
2,6-disubstituted piperidines and piperazine compounds
UNIV KENTUCKY RES FOUND0 citations42
BIOVENTURES LLC
6 patentsUS10071087B2Sep 11, 2018
Compositions and methods for selectively depleting senescent cells
BIOVENTURES LLC6 citations81
US10807977B2Oct 20, 2020
Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof
BIOVENTURES LLC2 citations71
US11319316B2May 3, 2022
Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof
BIOVENTURES LLC0 citations61
US10758524B2Sep 1, 2020
Compositions and methods for selectively depleting senescent cells
BIOVENTURES LLC1 citations59
US12118414B2Oct 15, 2024
BCL-2 proteins degraders for cancer treatment
BIOVENTURES LLC0 citations53
US12084423B2Sep 10, 2024
Piperlongumine analogues and uses thereof
BIOVENTURES LLC0 citations50
CROOKS PETER
5 patentsUS8846937B2Sep 30, 2014
Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
CROOKS PETER1 citations46
US8178678B2May 15, 2012
Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
CROOKS PETER1 citations45
US8299253B2Oct 30, 2012
Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
CROOKS PETER1 citations44
US8653275B2Feb 18, 2014
Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
CROOKS PETER0 citations43
US9540327B2Jan 10, 2017
Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
CROOKS PETER0 citations38